ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

VRDN Viridian Therapeutics Inc

16.30
1.72 (11.80%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Viridian Therapeutics Inc VRDN NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
1.72 11.80% 16.30 19:00:00
Open Price Low Price High Price Close Price Previous Close
15.08 15.01 15.50 15.40 14.58
more quote information »

Recent News

Date Time Source Heading
5/03/202407:00BWViridian Therapeutics Announces Inducement Grants Under..
4/29/202407:00BWViridian Therapeutics to Webcast First Quarter 2024..
4/04/202415:01BWViridian Therapeutics Announces Inducement Grants Under..
3/06/202415:01BWViridian Therapeutics Announces Inducement Grants Under..
3/05/202407:00BWViridian Therapeutics to Participate in the Leerink Partners..
2/28/202415:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/27/202415:07EDGAR2Form 8-K - Current report
2/27/202415:01BWViridian Therapeutics Highlights Recent Progress and Reports..
2/16/202407:00BWViridian Therapeutics Appoints Jennifer Tousignant as Chief..
2/14/202419:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202415:05EDGAR2Form 3 - Initial statement of beneficial ownership of..
2/14/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/14/202408:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202415:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/06/202415:01BWViridian Therapeutics Announces Inducement Grant Under..
1/24/202417:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/24/202416:12EDGAR2Form SC 13D/A - General statement of acquisition of..
1/19/202416:22EDGAR2Form 8-K - Current report
1/19/202415:32EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/17/202421:00BWViridian Therapeutics Announces Pricing of Public Offering..
1/17/202415:04EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
1/17/202415:01BWViridian Therapeutics Announces Proposed Underwritten Public..
1/12/202415:31EDGAR2Form 3 - Initial statement of beneficial ownership of..
1/08/202407:08EDGAR2Form 8-K - Current report
1/08/202407:00BWViridian Therapeutics to Present Key 2024 Corporate..
1/04/202407:00BWViridian Therapeutics to Webcast Presentation at the 42nd..
12/18/202310:45EDGAR2Form 144 - Report of proposed sale of securities
12/18/202307:15EDGAR2Form 8-K - Current report
12/18/202306:00BWViridian Therapeutics Announces Positive Clinical Data in..
12/12/202315:19EDGAR2Form 144 - Report of proposed sale of securities
12/08/202315:17EDGAR2Form SC 13G - Statement of acquisition of beneficial..
12/07/202315:22EDGAR2Form 144 - Report of proposed sale of securities
12/01/202315:04EDGAR2Form 144 - Report of proposed sale of securities
11/30/202315:05EDGAR2Form S-3ASR - Automatic shelf registration statement of..
11/21/202307:00BWViridian Therapeutics to Participate in 6th Annual Evercore..
11/13/202316:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202315:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202315:01BWViridian Therapeutics Reports Third Quarter 2023 Financial..
11/08/202307:00BWViridian Therapeutics to Participate in the Jefferies London..
11/03/202315:30EDGAR2Form SC 13D/A - General statement of acquisition of..
11/03/202307:00BWViridian Therapeutics Announces Encore Presentations at the..
11/01/202320:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202315:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/01/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202315:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202315:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
10/30/202307:35EDGAR2Form 8-K - Current report
10/30/202307:30BWViridian Therapeutics Appoints New Chief Executive Officer,..

Your Recent History

Delayed Upgrade Clock